Medgidas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 605,347 | 733,128 | 1,502,599 | 1,765,700 | 1,515,500 | 1,712,949 | 1,691,334 | 1,826,586 |
| Profit before tax | - | - | 705,400 | 812,679 | 589,339 | 725,464 | 738,277 | 801,774 |
| Net profit | 200,978 | 278,539 | 608,256 | 690,545 | 499,010 | 630,406 | 647,052 | 703,281 |
| Equity | 237,312 | 282,318 | 655,280 | 759,292 | 501,802 | 633,384 | 715,730 | 823,674 |
| Liabilities | 89,240 | 104,058 | 427,436 | 273,531 | 379,845 | 186,204 | 419,670 | 580,666 |
| Non-current assets | 26,571 | 22,591 | 87,545 | 63,373 | 54,222 | 42,504 | 138,983 | 112,391 |
| Current assets | 298,360 | 363,548 | 991,477 | 967,991 | 825,569 | 775,160 | 991,671 | 1,291,530 |
| Total assets | 324,931 | 386,139 | 1,079,022 | 1,031,364 | 879,791 | 817,664 | 1,130,654 | 1,403,921 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 529,483 | 512,038 | 618,889 |
| Social insurance contributions | - | - | - | - | - | - | 3,156 | 3,190 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +159.3% | +21.1% | +105.0% | +17.5% | -14.2% | +13.0% | -1.3% | +8.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 61.9% | 72.1% | 56.4% | 67.0% | 56.7% | 77.1% | 57.2% | 50.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 84.7% | 98.7% | 92.8% | 90.9% | 99.4% | 99.5% | 90.4% | 85.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 33.2% | 38.0% | 40.5% | 39.1% | 32.9% | 36.8% | 38.3% | 38.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 46.9% | 46.0% | 38.9% | 42.4% | 43.7% | 43.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.4 | 0.7 | 0.4 | 0.8 | 0.3 | 0.6 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 201,782 | 283,795 | 721,259 | 882,850 | 757,750 | 642,348 | 548,547 | 576,811 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medgidas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-07-16 | 2025-07-17 | 1138.11 |
| 2025-01-16 | 2025-01-19 | 197.28 |
| 2024-09-17 | 2024-09-24 | 849.44 |
| 2024-03-18 | 2024-03-27 | 56.86 |
| 2023-09-18 | 2023-09-20 | 773.63 |
| 2023-07-18 | 2023-07-20 | 1047.14 |
| 2023-06-16 | 2023-06-20 | 1181.22 |
| 2023-05-16 | 2023-05-17 | 601.67 |
| 2023-01-17 | 2023-01-18 | 13.07 |
| 2022-11-21 | 2022-12-04 | 6.01 |
| 2022-11-17 | 2022-11-18 | 6.01 |
| 2022-08-23 | 2022-08-24 | 436.10 |
| 2022-06-16 | 2022-06-19 | 132.68 |
| 2022-05-17 | 2022-05-18 | 542.98 |
| 2022-04-19 | 2022-04-21 | 561.27 |
| 2021-09-16 | 2021-09-21 | 62.68 |
Medgidas - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Medgidas is: 14 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 14.22 |
| 2026-08-28 | 2026-08-30 | 11890.17 |
| 2026-08-02 | 2026-08-27 | 10.17 |
| 2026-06-30 | 2026-08-01 | 1.8 |
| 2026-04-01 | 2026-04-26 | 9.13 |
| 2026-03-29 | 2026-03-31 | 3.53 |
| 2026-03-19 | 2026-03-24 | 3.53 |
| 2026-02-28 | 2026-03-11 | 3.53 |
| 2025-10-02 | 2025-10-03 | 2.33 |
| 2025-07-20 | 2025-07-26 | 1.06 |
| 2025-07-19 | 2025-07-19 | 0.06 |
| 2025-07-18 | 2025-07-18 | 843.42 |
| 2025-07-15 | 2025-07-17 | 842.73 |
| 2025-07-09 | 2025-07-14 | 841.35 |
| 2025-07-05 | 2025-07-08 | 862.06 |
| 2025-07-03 | 2025-07-04 | 25.83 |
| 2025-07-01 | 2025-07-02 | 25.81 |
| 2025-06-28 | 2025-06-30 | 25.76 |
| 2025-06-22 | 2025-06-25 | 25.76 |
| 2025-06-21 | 2025-06-21 | 19.32 |
| 2025-06-20 | 2025-06-20 | 23875.73 |
| 2025-06-19 | 2025-06-19 | 23862.85 |
| 2025-04-28 | 2025-04-28 | 36115.13 |
| 2025-04-08 | 2025-04-10 | 12.84 |
| 2025-04-04 | 2025-04-07 | 1000.59 |
| 2025-03-28 | 2025-04-03 | 12.84 |
| 2025-03-27 | 2025-03-27 | 0.08 |
| 2025-03-26 | 2025-03-26 | 0.07 |
| 2025-03-20 | 2025-03-25 | 32.06 |
| 2025-03-06 | 2025-03-12 | 9890.63 |
| 2025-03-02 | 2025-03-05 | 1.92 |
| 2025-02-22 | 2025-03-01 | 0.96 |
| 2025-02-20 | 2025-02-21 | 1770.9 |
| 2025-01-19 | 2025-01-26 | 28.94 |
| 2025-01-07 | 2025-01-10 | 1203.2 |
| 2024-12-22 | 2024-12-23 | 25.68 |
| 2024-12-21 | 2024-12-21 | 6.42 |
| 2024-12-19 | 2024-12-20 | 23801.0 |
| 2024-12-09 | 2024-12-18 | 29.58 |
| 2024-12-08 | 2024-12-08 | 35.99 |
| 2024-12-07 | 2024-12-07 | 36.28 |
| 2024-12-04 | 2024-12-06 | 29.58 |
| 2024-11-29 | 2024-12-03 | 47.62 |
| 2024-11-28 | 2024-11-28 | 36.82 |
| 2024-11-24 | 2024-11-27 | 19.04 |
| 2024-11-01 | 2024-11-23 | 67.14 |
| 2024-10-16 | 2024-10-31 | 6.51 |
| 2024-10-10 | 2024-10-15 | 1076.22 |
| 2024-10-03 | 2024-10-09 | 1069.71 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medgidas, UAB, a Private Limited Liability Company (code 303976411), operates in the retail sale of pharmaceutical products. In the latest financial year 2025, the company generated EUR 1.83 million in revenue and EUR 703.3 thousand in net profit, resulting in a 38.5% profit margin. Revenue increased by 8.0% year on year and by 6.6% over two years, showing a moderate upward trend after a small decline in 2024 from EUR 1.71 million in 2023 to EUR 1.69 million in 2024 and then higher sales in 2025. Profitability improved steadily across the period, with net profit rising from EUR 630.4 thousand in 2023 to EUR 647.1 thousand in 2024 and EUR 703.3 thousand in 2025. The balance sheet also expanded, with total assets increasing to EUR 1.40 million in 2025 from EUR 817.7 thousand in 2023. Equity reached EUR 823.7 thousand, liabilities EUR 580.7 thousand, and the debt-to-equity ratio was 0.70. Return on equity was 85.4%, return on assets 50.1%, and asset turnover 1.30x. Revenue per employee was EUR 608.9 thousand.